SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000939767-24-000040
Filing Date
2024-03-29
Accepted
2024-03-29 16:14:31
Documents
14
Period of Report
2024-03-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K exel-20240327.htm   iXBRL 8-K 21033
5 GRAPHIC exel-20240327_g1.jpg GRAPHIC 55431
  Complete submission text file 0000939767-24-000040.txt   278451

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20240327.xsd EX-101.SCH 1917
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20240327_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20240327_pre.xml EX-101.PRE 12522
17 EXTRACTED XBRL INSTANCE DOCUMENT exel-20240327_htm.xml XML 2709
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

IRS No.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 24804265
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)